SLC35F2 and hepatocellular carcinoma: Furthermore, we do not observe the heterogeneity of SLC35F2 expression associated with the HCC clinical tumor samples, indicating that SLC35F2 is unlikely to be the sole factor defining the heterogeneous sensitivity of HCC cells to YM155.